Selective alterations in insulin receptor substrates-1,-2 and -4 in theca but not granulosa cells from polycystic ovaries

Molecular Human Reproduction

Volumn 10, Issue 7, 2004, Pages 473-479

  Yen, H W ^a   Jakimiuk, A J ^b   Munir, I ^a   Magoffin, D A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Granulosa cell; Insulin receptor substrate; Insulin signalling; PCOS; Theca cell

Indexed keywords

ANDROGEN; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INSULIN RECEPTOR SUBSTRATE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVE SITE; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; MICRODISSECTION; OVARY CYCLE; OVARY FOLLICLE CELL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; THECA CELL; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ANIMALS; FEMALE; GRANULOSA CELLS; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; POLYCYSTIC OVARY SYNDROME; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; THECA CELLS;

EID: 4344640635     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah066     Document Type: Article

References (48)

1. Bjornholm M, He AR, Attersand A, Lake S, Liu SC, Lienhard GE, Taylor S, Arner P and Zierath JR (2002) Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 45,1697-1702.
2. Book CB and Dunaif A (1999) Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84,3110-3116.
3. Carmina E, Ditkoff EC, Malizia G, Vijod AG, Janni A and Lobo RA (1992) Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol 167,1819-1824.
4. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM and Yen SSC (1992) Cellular mechanisms of insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 75,577-583.
5. Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Yen SSC and Olefsky JM (1998) Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome. Metabolism 47,940-946.
6. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18,774-800.
7. Dunaif A and Thomas A (2001) Current concepts in the polycystic ovary syndrome. Annu Rev Med 52,401-419.
8. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A and Licholai T (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41,1257-1266.
9. Dunaif A, Xia J, Book C, Schenker E and Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 96,801-810.
10. Dunaif A, Wu X, Lee A and Diamanti-Kandarakis E (2001) Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281,E392-E399.
11. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL and Polonsky KS (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96,520-527.
12. Erickson GF, Magoffin DA, Dyer CA and Hofeditz C (1985) The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 6,371-399.
13. Fantin VR, Wang Q, Lienhard GE and Keller SR (2000) Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am J Physiol Endocrinol Metab 278,E127-E133.
14. Gilling-Smith C, Willis DS, Beard RW and Franks S (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 79,1158-1165.
15. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, Sbraccia P, Borboni P, Lauro R and Sesti G (2000) Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 16,434-441.
16. Goldzieher J and Green J (1962) The polycystic ovary: clinical and histologic features. J Clin Endocrinol 22,325.
17. Jacobs S and Cuatrecasas P (1981) Insulin receptor: structure and function. Endocr Rev 2,251-263.
18. Jakimiuk AJ, Weitsman SR, Brzechffa PR and Magoffin DA (1998) Aromatase messenger ribonucleic acid expression in individual follicles from polycystic ovaries. Mol Hum Reprod 4,1-8.
19. Jakimiuk AJ, Weitsman SR, Navab A and Magoffin DA (2001) Luteinizing hormone receptor, steroidogenesis acute regulatory protein and steroidogenic enzyme messenger ribonucleic acids are over-expressed in theca and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86, 1318-1323.
20. Kahn CR (1985) The molecular mechanism of insulin action. Annu Rev Med 36,429-451.
21. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR and Lienhard GE (1997a) A novel 160kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272,21403-21407.
22. Lavan BE, Lane WS and Lienhard GE (1997b) The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272,11439-11443.
23. Legro RS, Finegood D and Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83,2694-2698.
24. Mahajan DK (1988) Steroidogenesis in human polycystic ovary. Endocrinol Metab Clin N Am 17,751-769.
25. Marsden PJ, Murdoch A and Taylor R (1994) Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. Metabolism 43,1536-1542.
26. Marsden PJ, Murdoch AP and Taylor R (2001) Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol (Oxf) 55, 191-199.
27. Meirow D, Yossepowitch O, Rosler A, Brzezinski A, Schenker JG, Laufer N and Raz I (1995) Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups. Hum Reprod 10,1951-1956.
28. Munir I, Yen HW, Geller DH, Torbati D, Bierden R, Weitsman SR, Agarwal SK and Magoffin DA (2004) Insulin stimulation of 17α-hydroxylase activity is mediated by phosphatidylinositol 3-kinase but not ERK1/2 in human ovarian theca cells. Endocrinology 145,175-183.
29. Nestler JE and Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335,617-623.
30. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N and Medina F (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol glycan mediators as the signal transduction system. J Clin Endocrinol Metab 83,2001-2005.
31. Polson DW, Adams J, Wadsworth J and Franks S (1988) Polycystic ovaries - a common finding in normal women. Lancet i,870-872.
32. Roth RA and Cassell DJ (1983) Insulin receptor: evidence that it is a protein kinase. Science 219,299-301.
33. Sciachitano S and Taylor SI (1997) Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology 138, 4931-4940.
34. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P and Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15,2099-2111.
35. Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers MGJ, Glasheen E, Copeland NG, Jenkins NA, Pierce JH and White MF (1997) The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol Endocrinol 11,251-262.
36. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ and White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77.
37. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MGJ, Glasheen E, Lane WS, Pierce JH and White MF (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377,173-177.
38. Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S and Clayton RN (1996) Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 81,1979-1983.
39. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y and Satoh S (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372,182-186.
40. Tsuruzoe K, Emkey R, Kriauciunas KM, Ueki K and Kahn CR (2001) Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling. Mol Cell Biol 21,26-38.
41. Uchida T, Myers MG, Jr and White MF (2000) IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis. Mol Cell Biol 20,126-138.
42. Velazquez EM, Mendoza S, Hamer T, Sosa F and Glueck CJ (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43,647-654.
43. Virkamaki A, Ueki K and Kahn CR (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103,931-943.
44. White MF and Yenush L (1998) The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228,179-208.
45. Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss JF, III and McAllister JM (2000) Differential activity of the cytochrome P450 17α-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 58,2304-2311.
46. Willis D and Franks S (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80,3788-3790.
47. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S and White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391,900-904.
48. Wu X, Sallinen K, Anttila L, Makinen M, Luo C, Pollanen P and Erkkola R (2000) Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls. Fertil Steril 74,564-572.